ETFs
C
CNMD
Conmed Corp
39.08
+1.17+3.09%After Hours: 39.00 -0.08 -0.21%17:48 04/17 EDT
OPEN/PREV CLOSE40.04/39.68
TODAY RANGE38.25-40.64
VOL307.81K
MARKET CAP1.16B
52 WEEK RANGE33.21-60.63
AVG VOL (3M)499.10K
% TURNOVER1.02%
TURNOVER--
P/E (TTM)25.40
% RANGE6.02%
EPS(TTM)1.511
P/E(FORWARD)9.89
P/B1.150
BVPS33.36
DIVIDEND--
P/S0.8644
BETA--
DIV YIELD0.00%
FREE FLOAT MKT CAP1.15B
SHARES OUTSTANDING30.14M
NEXT EARNINGS04/28-05/04
FREE FLOAT30.02M
LOT SIZE1
EX-DATE09/15/2025
News
Press Releases
Financial Reports
Profile
Simply Wall St·04/12 22:22
CONMED (CNMD) Is Up 5.6% After Q4 Beat But Cut Full-Year Outlook - What's Changed
Simply Wall St·04/11 03:31
A Look At CONMED’s (CNMD) Valuation After Mixed Q4 Beat And Full Year Guidance Miss
NASDAQ·04/09 15:16
Here's Why You Should Retain CONMED Stock in Your Portfolio Now
NASDAQ·04/06 22:50
RSI Alert: CONMED (CNMD) Now Oversold
NASDAQ·03/25 13:24
Are Options Traders Betting on a Big Move in CONMED Stock?
Simply Wall St·03/24 04:28
Will CONMED’s New Interim Finance Chief Reframe Its Slowing Growth Story for Investors (CNMD)?
Simply Wall St·03/22 02:08
Is It Time To Reassess CONMED (CNMD) After A 39% One Year Share Price Slide
Simply Wall St·03/20 06:12
CONMED Refocuses Portfolio As Gastroenterology Exit And Interim CFO Shift Unfold
Seeking Alpha·03/17 15:28
CONMED cut to Neutral at Piper Sandler on lack of catalysts
TipRanks·03/17 13:36
DraftKings, Eli Lilly downgraded: Wall Street’s top analyst calls
Dow Jones·03/17 10:12
Conmed Price Target Cut to $39.00/Share From $55.00 by Piper Sandler
Dow Jones·03/17 10:12
Conmed Cut to Neutral From Overweight by Piper Sandler
Same Industry
Name/Symbol
Change%
Price